Quinazoline, 4-[(4-bromophenyl)methoxy]- Chemical Properties

Boiling point:

455.0±25.0 °C(Predicted)

Density 

1.494±0.06 g/cm3(Predicted)

storage temp. 

Store at -20°C

solubility 

DMSO: 63 mg/mL (199.90 mM);Ethanol: 3 mg/mL (9.52 mM)

pka

2.66±0.30(Predicted)

form 

Solid

color 

White to off-white

Water Solubility 

Water: Insoluble

Quinazoline, 4-[(4-bromophenyl)methoxy]- Usage And Synthesis

Biological Activity

WAY-340935 (VEGFR2-IN-2) can inhibit the function of VEGFR2 and the anti-proliferative activity against the H460 cell line is produced partly by interaction of VEGFR protein.

References

[1] Sun J, et al. Org Biomol Chem. 2013 Nov 28;11(44):7676-86.

Quinazoline, 4-[(4-bromophenyl)methoxy]-(737818-56-3)Related Product Information

• 1H-1,2,4-Triazole-3-carboxamide, 1-(3-chloro-4-fluorophenyl)-N-(3,4-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-
• VEGFR3/FLT4 Protein, Human, Recombinant (His & Avi)
• 3-nitro-N-(8-quinolinyl)benzamide
• 2-Quinazolinecarboxylic acid, 4-[3-fluoro-4-[[[(3-methylphenyl)amino]carbonyl]amino]phenoxy]-, ethyl ester
• Pazopanib Impurity 3
• Benzoic acid, 4-[[4-[[2-[2,4-dioxo-5-(phenylmethylene)-3-thiazolidinyl]acetyl]amino]benzoyl]amino]-, ethyl ester
• VEGFR3/FLT4 Protein, Human, Recombinant (aa 25-776, His & Avi), Biotinylated
• 3-Pyridinecarbonitrile, 2-hydrazinyl-6-(2-naphthalenyl)-4-(4-nitrophenyl)-
• 2,4-PyriMidinediaMine with linker